Is it time for ACE inhibitors in chronic allograft nephropathy?

This publication has 15 references indexed in Scilit:

• Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
  The Lancet, 1997
• Effect of Captopril on Progression to Clinical Proteinuria in Patients With Insulin-Dependent Diabetes Mellitus and Microalbuminuria
  JAMA, 1994
• The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
  New England Journal of Medicine, 1993
• Long-Term Stabilizing Effect of Angiotensin-Converting Enzyme Inhibition on Plasma Creatinine and on Proteinuria in Normotensive Type II Diabetic Patients
  Annals of Internal Medicine, 1993
• Renal protective effect of enalapril in diabetic nephropathy.
  BMJ, 1992
• Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy.
  BMJ, 1986
• Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension.
  Journal of Clinical Investigation, 1986
• Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy.
  Proceedings of the National Academy of Sciences, 1985
• EARLY AGGRESSIVE ANTIHYPERTENSIVE TREATMENT REDUCES RATE OF DECLINE IN KIDNEY FUNCTION IN DIABETIC NEPHROPATHY
  The Lancet, 1983
• Progression of Nephropathy in Long-Term Diabetics with Proteinuria and Effect of Initial Anti-Hypertensive Treatment
  Scandinavian Journal of Clinical and Laboratory Investigation, 1976